Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinichi Yoshioka

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|November 30, 2006
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancerShin Nakahira, Shoji Nakamori, Masanori Tsujie, et al.
The Oncologist|May 12, 2021
Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver MetastasesHironaga Satake, Hiroki Hashida, Hiroaki Tanioka, et al.
Oncology Reports|February 9, 2006
Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significanceDi Tang, Hiroaki Nagano, Hirofumi Yamamoto, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2017
Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancerKatsuki Danno, Taishi Hata, Koki Tamai, et al.
Cancers|October 16, 2024
Tolerability and Safety Assessment of Adjuvant Chemoradiotherapy with S-1 after Limited Surgery for T1 or T2 Lower Rectal CancerNorikatsu Miyoshi, Mamoru Uemura, Shingo Noura, et al.
Scientific Reports|November 3, 2024
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancerTaishi Hata, Mamoru Uemura, Katsuki Danno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2006
Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alphaHiroshi Wada, Hiroaki Nagano, Hirofumi Yamamoto, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 1, 2025
A multicentre prospective single-arm clinical trial to evaluate the treatment outcomes of prophylactic laparoscopic lateral pelvic lymph node dissection for advanced lower rectal cancerAtsushi Hamabe, Junichi Nishimura, Yozo Suzuki, et al.
Hepato-Gastroenterology|April 11, 2007
Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasionIsao Arai, Hiroaki Nagano, Motoi Kondo, et al.
Surgery|November 8, 2024
Influence of the rotation of the diverting loop ileostomy in rectal cancer surgery on small-bowel obstruction: A multicenter prospective study conducted by the Clinical Study Group of Osaka University, Colorectal GroupMasaaki Miyo, Mamoru Uemura, Yuki Ozato, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|November 30, 2006
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancerShin Nakahira, Shoji Nakamori, Masanori Tsujie, et al.
The Oncologist|May 12, 2021
Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver MetastasesHironaga Satake, Hiroki Hashida, Hiroaki Tanioka, et al.
Oncology Reports|February 9, 2006
Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significanceDi Tang, Hiroaki Nagano, Hirofumi Yamamoto, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2017
Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancerKatsuki Danno, Taishi Hata, Koki Tamai, et al.
Cancers|October 16, 2024
Tolerability and Safety Assessment of Adjuvant Chemoradiotherapy with S-1 after Limited Surgery for T1 or T2 Lower Rectal CancerNorikatsu Miyoshi, Mamoru Uemura, Shingo Noura, et al.
Scientific Reports|November 3, 2024
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancerTaishi Hata, Mamoru Uemura, Katsuki Danno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2006
Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alphaHiroshi Wada, Hiroaki Nagano, Hirofumi Yamamoto, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 1, 2025
A multicentre prospective single-arm clinical trial to evaluate the treatment outcomes of prophylactic laparoscopic lateral pelvic lymph node dissection for advanced lower rectal cancerAtsushi Hamabe, Junichi Nishimura, Yozo Suzuki, et al.
Hepato-Gastroenterology|April 11, 2007
Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasionIsao Arai, Hiroaki Nagano, Motoi Kondo, et al.
Surgery|November 8, 2024
Influence of the rotation of the diverting loop ileostomy in rectal cancer surgery on small-bowel obstruction: A multicenter prospective study conducted by the Clinical Study Group of Osaka University, Colorectal GroupMasaaki Miyo, Mamoru Uemura, Yuki Ozato, et al.
Pageof 10